A citation-based method for searching scientific literature

R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
Times Cited: 244



Julio Rosenstock, Alice Cheng, Robert Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías, Ronan Roussel, Geremia B Bolli. Diabetes Care 2018
Times Cited: 105




List of shared articles



Times cited

Comparison of Second-Generation Basal Insulin Analogs: A Review of the Evidence from Continuous Glucose Monitoring.
Tadej Battelino, Steven V Edelman, Rimei Nishimura, Richard M Bergenstal. Diabetes Technol Ther 2021
3

Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL-1 and Insulin Degludec 100 units · mL-1 in Type 1 Diabetes.
Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci, Angela Gambelunghe, Geremia B Bolli, Carmine G Fanelli, Francesca Porcellati. Diabetes Care 2021
8


Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study.
Stewart B Harris, Olubukola Ajala, Basel Bari, Joanne Liutkus, Jina Hahn, Oliver Martyn, Deborah Zwicker. Diabetes Ther 2021
0

One hundred years of insulin therapy.
Chantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven. Nat Rev Endocrinol 2021
2



Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy.
Steffen Haldrup, Annunziata Lapolla, Jens Gundgaard, Michael L Wolden. J Med Econ 2020
4

Insulin Therapy in Type 2 Diabetes.
Pablo Aschner. Am J Ther 2020
6

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study.
Alice Cheng, Stewart Harris, Francesco Giorgino, Jochen Seufert, Robert Ritzel, Kamlesh Khunti, Felipe Lauand, Lydie Melas-Melt, Jukka Westerbacka, Zsolt Bosnyak,[...]. Diabetes Obes Metab 2020
3

The importance of the initial period of basal insulin titration in people with diabetes.
Kamlesh Khunti, Francesco Giorgino, Lori Berard, Didac Mauricio, Stewart B Harris. Diabetes Obes Metab 2020
10

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.
Athena Philis-Tsimikas, David C Klonoff, Kamlesh Khunti, Harpreet S Bajaj, Lawrence A Leiter, Melissa V Hansen, Lone N Troelsen, Steen Ladelund, Simon Heller, Thomas R Pieber. Diabetologia 2020
30

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes.
Michele Schiavon, Roberto Visentin, Clemens Giegerich, Jochen Sieber, Chiara Dalla Man, Claudio Cobelli, Thomas Klabunde. Diabetes Technol Ther 2020
7



Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
Lorraine Lipscombe, Sonia Butalia, Kaberi Dasgupta, Dean T Eurich, Lori MacCallum, Baiju R Shah, Scot Simpson, Peter A Senior. Can J Diabetes 2020
33




Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Drugs 2019
12


Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study.
Jeremy Pettus, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Jukka Westerbacka, Rachele Berria, Javier Jimenez, Björn Eliasson, Irene Hramiak, Timothy Bailey,[...]. Diabetes Ther 2019
36